Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title New generation vaccines / edited by Myron M. Levine [and others].
Imprint New York : M. Dekker, 1997.
Edition 2nd ed., rev. and expanded.

View online
View online
Subject Vaccines.
Alt Name Levine, Myron M. (Myron Max), 1944-
Description 1 online resource (xvi, 1214 pages) : illustrations
Edition 2nd ed., rev. and expanded.
Bibliography Note Includes bibliographical references and index.
Note Print version record.
ISBN 0585340188 (electronic bk.)
9780585340180 (electronic bk.)
0824700619 (hardcover ; alk. paper)
OCLC # 47010008
Additional Format Print version: New generation vaccines. 2nd ed., rev. and expanded. New York : M. Dekker, 1997 0824700619 (DLC) 97012541 (OCoLC)36682381
Table of Contents
1Vaccines and Vaccination in Historical Perspective / Myron M. Levine, Rosanna Lagos1
2The Traditional Vaccines: An Overview / Gordon L. Ada13
3An Overview of Biotechnology as Applied to Vaccine Development / Graeme C. Woodrow25
4Initial Clinical Evaluation of New Vaccine Candidates: Phase 1 and 2 Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy / Carol O. Tacket, Tacket J. Mattheis, Margaret Baker Rennels35
5Long-Term Evaluation of Vaccine Protection: Methodological Issues for Phase 3 Trials and Phase 4 Studies / John D. Clemens, Abdollah Naficy, Malla R. Rao47
6Economic Analyses of Vaccines and Vaccination Programs: Evaluating the Economic Rationale for Immunization / Orin S. Levine, Benjamin Schwartz69
7Reaping the Benefits: Getting Vaccines to Those Who Need Them / J. W. Lee, Bruce Aylward, Harry F. Hull [et al.]79
8Progress and Challenges in Modern Vaccinology: An Immunologist's Perspective / Gustav J. V. Nossal89
9The Eradication of Vaccine-Preventable Diseases / William Foege93
10Recent Advances in Immunology: Impact on Vaccine Development / Marcelo B. Sztein, Graham F. Mitchell99
11Computer Prediction of T-Cell Epitopes / Anne S. De Groot, Gabriel E. Meister, James L. Cornette [et al.]127
12Identification of B- and T-Cell Epitopes Through Structural Characterization and Peptide Technology / Juan A. Cooper, Allan J. Saul139
13The Gastrointestinal Mucosal Immune System / Stephen P. James151
14Adjuvants for the Future / Robert Edelman173
15Proteosomes for Improved Nasal, Oral, or Injectable Vaccines / George H. Lowell193
16Liposomes as Adjuvants for Vaccines / Carl R. Alving207
17Prospects for the Development of New and Improved Vaccines Through the Use of Microencapsulation Technology / Derek T. O'Hagan215
18Antigen Cochleate Preparations for Oral and Systemic Vaccination / Raphael J. Mannino, Susan Gould-Fogerite229
19Ty Virus-like Particles as an Antigen Delivery System / Guy T. Layton239
20Immunopotentiating Reconstituted Influenza Virosomal Vaccine Delivery System / Reinhard Gluck, Stanley J. Cryz, Jr.247
21Mutant Pertussis and Escherichia coli Heat-Liable Toxins as Adjuvants for Enhancing Local and Systemic Immune Responses to Coadministered, Nonliving Antigens / Gillian Douce, Gordon Dougan, MariaGrazia Pizza [et al.]253
22Oral Vaccine Production in the Edible Tissues of Transgenic Plants / Charles J. Arntzen, Hugh S. Mason263
23DNA-Based Vaccines: Extending the Technology / Stephen Albert Johnston, Kathryn F. Sykes, Michael A. Barry279
24Vaccination Against Influenza with Plasmid DNA: Cross-Strain and Homologous Protection / John J. Donnelly, Jeffrey B. Ulmer, Margaret A. Liu287
25Vaccinia Virus as a Live Vector for Expression of Immunogens / Charles Flexner, Bernard Moss297
26Attenuated Poliovirus as Live Vector / Matthias Gromeier, Hui-Hua Lu, Steffen Mueller [et al.]315
27Attenuated Salmonella as a Live Vector for Expression of Foreign Antigens331
 iExpressing Bacterial Antigens / S. N. Chatfield, Gordon Dougan331
 iiCarrying Viral Antigens / Fiorian Schodel343
 iiiSalmonella Expressing Protozoal Antigens / Myron M. Levine, James E. Galen, Marcelo B. Sztein [et al.]351
28BCG as a Recombinant Vaccine Vector / Glenn J. Fennelly, William R. Jacobs, Jr., Barry R. Bloom363
29Attenuated Vibrio cholerae as a Live Vector for Expression of Foreign Antigens / Joan R. Butterton, Stephen B. Calderwood379
30New and Improved Vaccines Against Pertussis / Erik L. Hewlett, James D. Cherry387
31New and Improved Vaccines Against Diphtheria and Tetanus / Rino Rappuoli417
32Progress in Development of New Attenuated Strains of Salmonella typhi as Live Oral Vaccines Against Typhoid Fever / Myron M. Levine, Carol O. Tacket, James E. Galen [et al.]437
33New and Improved Vaccines Against Cholera447
 iAttenuated Vibrio cholerae O1 and O139 Strains as Live Oral Cholera Vaccines / James B. Kaper, Carol O. Tacket, Myron M. Levine447
 iiOral B Subunit Killed Whole-Cell Cholera Vaccine / Jan Holmgren, Marianne Jertborn, Ann-Mari L. Svennerholm459
34New and Improved Vaccines Against Meningococcal Disease / Wendell D. Zollinger469
35Epidemiological Impact of Conjugate Vaccines on Invasive Disease Caused by Haemophilus influenzae Type b / Jay D. Wenger, Robert Booy, Paul T. Heath [et al.]489
36Conjugate Vaccines Against Streptococcus pneumoniae / David L. Klein, Ronald W. Ellis503
37Vaccine Development for Rickettsial Infections: Rocky Mountain Spotted Fever, Epidemic Typhus, and Scrub Typhus / Kimberly W. Schuenke, David H. Walker527
38New and Improved Vaccines Against Influenza / Mary Lou Clements, Ina Stephens545
39New Vaccines Against Hepatitis A / Jack T. Stapleton, Stanley M. Lemon571
40New and Improved Vaccines for Dengue, Japanese Encephalitis, and Yellow Fever Viruses / Niranjan Kanesa-thasan, Robert Putnak, Charles H. Hoke, Jr.587
41Improved Vaccines Against Rabies / Zhen Fang Fu, Bernhard Dietzschold, Stanley A. Plotkin [et al.]607
42Combination Vaccines for Routine Infant Immunization: Prospects, Progress, and Dilemmas / Carole Heilman, N. Regina Rabinovich619
43New Vaccines Against Tuberculosis / Douglas Young, Uli Fruth631
44Live Attenuated Varicella Vaccines / Michiaki Takahashi, Anne A. Gershon647
45Vaccines Against Rotavirus / Paul A. Offit, H. Fred Clark, Albert Z. Kapikian659
46Experimental HIV-1 Vaccines / Mary Lou Clements673
47Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 / James E. Crowe, Jr., Peter L. Collins, Robert M. Chanock [et al.]711
48Herpes Simplex Vaccines / Richard J. Whitley727
49Vaccines Against Arenaviruses and Filoviruses / J. Christopher S. Clegg, Anthony Sanchez749
50Vaccines Against Papillomavirus Infections / Robert W. Tindle, Ian H. Frazer767
51Vaccines Against Streptococcus pyogenes Infections / Debra E. Bessen, Vincent A. Fischetti783
52O-Specific Polysaccharide-Protein Conjugates for Prevention of Enteric Bacterial Diseases / John B. Robbins, Rachel Schneerson, Shousun C. Szu803
53Vaccines Against Gonococcal Infection / Timothy A. Mietzner, Myron S. Cohen817
54Vaccines Against Shigella Infections843
 iEscherichia coli- or Salmonella typhi-Expressing Shigella Antigens / Thomas Larry Hale, Malabi M. Venkatesan843
 iiEngineered Attenuated Mutants of Shigella as Live Oral Vaccines / Fernando Noriega, Samuel B. Formal, Karen L. Kotloff [et al.]853
55Vaccines Against Enterotoxigenic Escherichia coli Infections865
 iOral Inactivated Vaccines Against Enterotoxigenic Escherichia coli / Ann-Mari L. Svennerholm, Christina Ahren, Marianne Jertborn865
 iiLive Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines / Carol O. Tacket, Myron M. Levine875
56Vaccines Against Campylobacter jejuni / Daniel A. Scott, Shahida Baqar, Donald H. Burr [et al.]885
57Vaccines Against Lyme Disease / Robert Edelman897
58Vaccines Against Dental Caries Infection / Daniel J. Smith, Martin A. Taubman913
59Vaccines Against Klebsiella, Pseudomonas, and Septicemic E. coli Infections / Alan S. Cross, Stanley J. Cryz, Jr.931
60Vaccines Against Escherichia coli and Proteus Urinary Tract Infections / Harry L. T. Mobley945
61Vaccines Against Helicobacter pylori / Adrian Lee, Christopher Doidge963
62Vaccines for Staphylococcus aureus Infections / Ali I. Fattom, Robert B. Naso979
63Vaccines Against Malaria989
 iSynthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium / Elizabeth H. Nardin, Ruth S. Nussenzweig989
 iiVaccines Designed to Induced Protective T-Cell Responses Against Plasmodium-Infected Hepatocytes / John B. Sacci, Jr., Eileen D. Franke, Stephen L. Hoffman1009
 iiiSpf66 Vaccine Against Asexual Erythrocytic Stages of P. falciparum / Roberto Amador, Manuel E. Patarroyo1027
 ivVaccines Against Asexual Blood Stages of Plasmodium falciparum / Robin F. Anders1035
 vVaccines Against Sexual-Stage Parasites of P. falciparum: Transmission-Blocking Vaccines / David C. Kaslow1057
64Vaccines Against Leishmaniasis / Carol L. Eisenberger, Charles L. Jaffe1065
65Vaccines Against Schistosomiasis / Gilles J. Riveau, Andre Capron1081
66Antitumor Vaccines / Karl Erik Hellstrom, Ingegerd Hellstrom, Lieping Chen1095
67Vaccine Therapy / Donald S. Burke1117
68Vaccines to Prevent Pregnancy / Vernon C. Stevens, Warren R. Jones1131
69An Anti-arthropod Vaccine: TickGARD - A Vaccine to Prevent Cattle Tick Infestations / Gary S. Cobon1145
70Large-Scale Production of Live Attenuated Bacterial and Viral Vaccines / Stanley J. Cryz, Jr., Reinhard Gluck1153
71Vaccine Development: The Long Road from Initial Idea to Product Licensure / Jens-Peter Gregersen1165
72Inadvertant Nontarget Effects of Live Vaccines / Myron M. Levine, Eileen M. Barry1179
73The Role of the Food and Drug Administration in Vaccine Testing and Licensure / Bascomb F. Anthony, Ann Sutton1185

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team